It is continuously researched for a number of therapeutic applications in relation to its healing potential, which could be used to overcome soft and hard tissue injuries, GI disorders, and inflammatory diseases, just to name a few conditions [2, 3, 4, 5, 6]
Edward Zawadzki, now the medical director at Beach House Center for Recovery, recalled treating patients during his residency who had been rushed into the ER with a BAC as high as .30, .40 and even .50
Notably, most published human trial data involves a different, full-length recombinant version of thymosin beta-4 developed by a pharmaceutical sponsor, not the short synthetic fragment sold online as TB-500
Clinical efficacy in humans is still being researched
Neither is better
As metabolic science continues to evolve, compounds like this remain important components of structured testing programs